“In May, we partnered with
“Since the quarter end, we signed a memorandum of understanding with
Financial Highlights
Working capital was approximately
Cash Flows Summary
At
- Cash used in operating activities for the six months ended
June 30, 2026 , was$8.3 million , an increase of$2.7 million compared to$5.6 million for the six months endedJune 30, 2025 . The increase was primarily due to increased cash expenditures on R&D and G&A expenses, partially offset by higher interest income, reflecting increased average cash balances resulting from proceeds received through the Company's at-the-market (ATM) equity offering program. - Cash provided by financing activities for the six months ended
June 30, 2026 , was$43.9 million , a decrease of$19.6 million compared to$63.5 million for the six months endedJune 30, 2025 . This decrease was primarily due to a$18.7 million decrease in net proceeds received from the issuance of common stock under our ATM program. The Company sold an aggregate of 3.8 million shares during the six months endedJune 30, 2026 , compared to an aggregate of 6.2 million shares during the six months endedJune 30, 2025 .
Second Quarter 2026 Operations Summary
- General and administrative expenses amounted to
$3.7 million for the quarter endedJune 30, 2026 , compared to$2.5 million for the quarter endedJune 30, 2025 . The$1.2 million increase was primarily due to a$0.9 million increase in employee compensation and stock-based compensation for employees, contractors, and directors, reflecting new hires, increased bonuses, and several new stock-based awards, including performance stock awards. Total stock-based compensation included in G&A expenses was$1.0 million and$0.5 million for the three months endedJune 30, 2026 , andJune 30, 2025 , respectively. - Lightbridge’s total R&D expenses amounted to
$4.0 million for the quarter endedJune 30, 2026 , compared to$1.6 million for the quarter endedJune 30, 2025 , an increase of$2.4 million . The increase was primarily due to a$1.4 million increase in employee compensation and stock-based compensation, reflecting an increase in new hires, increased employee bonuses, and several new stock-based awards, including performance stock awards; a$0.4 million increase in R&D project development costs related to cladding, critical heat flux testing, safety analysis, and feasibility studies; and a$0.2 million increase inIdaho National Laboratory (INL) project labor costs, as we entered into additional agreement modifications and new project task statements (PTSs). Total stock-based compensation included in R&D expenses was$0.4 million and$0.2 million for the three months endedJune 30, 2026 , and 2025, respectively.
- During the second quarter of 2026, the Company recorded a total reversal of
$0.7 million of previously recognized stock-based compensation related to performance-based awards after the related performance condition was determined to no longer be probable of achievement. Of this amount,$0.5 million reduced general and administrative expense and$0.2 million reduced R&D expense for both the three months and six months endedJune 30, 2026 . - Total other income was
$1.9 million for the quarter endedJune 30, 2026 , compared to$0.6 million for the quarter endedJune 30, 2025 . Other income consisted of interest income earned from treasury bills and our bank savings account, driven by higher average cash balances. - Net loss was
$5.8 million for the quarter endedJune 30, 2026 , compared to$3.5 million for the quarter endedJune 30, 2025 .
Six Months Ended
- General and administrative expenses amounted to
$8.0 million for the six months endedJune 30, 2026 , compared to$6.0 million for the six months endedJune 30, 2025 . The$2.0 million increase was primarily due to a$1.5 million increase in employee compensation and stock-based compensation for employees, contractors, and directors, reflecting new hires, increased bonuses, and several new stock-based awards, including performance stock awards, and additional stock-based compensation in the prior period from the accelerated vesting of certain awards. Total stock-based compensation included in G&A expenses was$2.8 million and$1.6 million for the six months endedJune 30, 2026 , andJune 30, 2025 , respectively. - Lightbridge’s total R&D expenses amounted to
$7.3 million for the six months endedJune 30, 2026 , compared to$3.3 million for the six months endedJune 30, 2025 , an increase of$4.0 million . The increase was primarily due to a$2.4 million increase in employee compensation and stock-based compensation, reflecting an increase in new hires, increased employee bonuses, and several new stock-based awards, including performance stock awards; a$0.7 million increase in IT expenses, which include additional computer hardware, software, and operating expenses related to the Company’s high-performance computer; a$0.4 million increase in R&D project development costs related to cladding, critical heat flux testing, safety analysis, and feasibility studies; and a$0.2 million increase in INL project labor costs, as we entered into additional agreement modifications and new PTSs. Total stock-based compensation included in R&D expenses was$1.1 million and$0.4 million for the six months endedJune 30, 2026 , and 2025, respectively. - Total other income was
$3.2 million for the six months endedJune 30, 2026 , compared to$1.0 million for the six months endedJune 30, 2025 . Other income consisted of interest income earned from treasury bills and our bank savings account, driven by higher average cash balances. - Net loss was
$12.1 million for the six months endedJune 30, 2026 , compared to$8.3 million for the six months endedJune 30, 2025 .
CONFERENCE CALL & AUDIO WEBCAST
To join the call by phone, please register using this link (registration link), and you will receive dial-in details. To avoid delays, we encourage participants to dial in to the conference call 15 minutes before the scheduled start time. The webcast can be accessed at the following link (webcast).
A webcast replay will also be available for a limited time at the following link (webcast replay).
About Lightbridge Corporation
Lightbridge Corporation (NASDAQ: LTBR) is focused on developing advanced nuclear fuel technology essential to delivering abundant, zero-emission, clean energy and providing energy security to the world. The Company is developing Lightbridge Fuel™, a proprietary next-generation nuclear fuel technology for existing light-water and pressurized heavy-water reactors, significantly enhancing reactor safety, economics, and proliferation resistance. The Company is also developing Lightbridge Fuel for new small modular reactors to deliver the same benefits, when combined with load-following with renewables, on a zero-carbon electric grid.
Lightbridge has entered into two long-term framework agreements with Battelle Energy Alliance, LLC, the United States Department of Energy’s operating contractor for Idaho National Laboratory, the United States’ lead nuclear energy research and development laboratory. DOE’s Gateway for Accelerated Innovation in Nuclear program has twice awarded Lightbridge to support the development of Lightbridge Fuel over the past several years. An extensive worldwide patent portfolio backs Lightbridge’s innovative fuel technology. Lightbridge is included in the Russell 2000®, Russell 3000®, and Solactive Global Uranium & Nuclear Components Total Return Indexes. For more information, please visit www.ltbridge.com.
To receive Lightbridge Corporation updates via e-mail, subscribe at https://www.ltbridge.com/investors/news-events/email-alerts
Lightbridge is on YouTube. Subscribe to access past demonstrations, interviews, and other video content at https://www.youtube.com/@lightbridgecorporation
Lightbridge is on X (formerly Twitter). Sign up to follow @LightbridgeCorp at http://twitter.com/lightbridgecorp.
Forward-Looking Statements
With the exception of historical matters, the matters discussed herein are forward-looking statements. These statements are based on current expectations on the date of this news release and involve a number of risks and uncertainties that may cause actual results to differ significantly from such estimates. The risks include, but are not limited to: Lightbridge’s ability to commercialize its nuclear fuel technology, including risks related to the design and testing of nuclear fuel incorporating its technology and the degree of market adoption of Lightbridge’s product and service offerings; dependence on strategic partners; any adverse changes to Lightbridge’s agreements or relationship with the U.S. government and its national laboratories; Lightbridge’s ability to fund its future operations, including general corporate overhead and outside research and development expenses, and continue as a going concern; the future market and demand for Lightbridge’s fuel for nuclear reactors and its ability to attract customers; Lightbridge’s ability to manage the business effectively in a rapidly evolving market; Lightbridge’s ability to employ and retain qualified employees and consultants that have experience in the nuclear industry; competition and competitive factors in the markets in which Lightbridge competes, including from accident-tolerant fuels; access to and availability of nuclear test reactors and the risks associated with unexpected changes in Lightbridge’s nuclear fuel development timeline; access to and availability of adequate resources and manufacturing capabilities at national laboratories that affect our nuclear fuel development timeline and project costs; Lightbridge’s ability to deploy and operate a dedicated nuclear fuel fabrication facility; the increased costs associated with metallization of Lightbridge’s nuclear fuel; uncertainties related to conducting business in foreign countries; public perception of nuclear energy generally; changes in laws, rules, and regulations governing Lightbridge’s business; changes in the political environment; development and utilization of, and challenges to, Lightbridge’s intellectual property domestically and abroad; the volatility of the trading price of Lightbridge’s securities and the potential for purchasers of its securities to incur substantial losses; and other factors described in Lightbridge’s filings with the Securities and Exchange Commission (the “SEC”). Lightbridge does not assume any obligation to update or revise any such forward-looking statements, whether as a result of new developments or otherwise, except as required by law. Readers are cautioned not to put undue reliance on forward-looking statements.
A further description of risks and uncertainties can be found in Lightbridge’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and in its other filings with the SEC, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Statements,” all of which are available at http://www.sec.gov/ and www.ltbridge.com.
Investor Relations Contact:
Matthew Abenante, IRC
Director of Investor Relations
Tel: +1 (347) 947-2093
ir@ltbridge.com
*** tables follow ***
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||
| 2026 | 2025 | ||||||||
| Current Assets | |||||||||
| Cash and cash equivalents | $ | 237,466,174 | $ | 201,862,421 | |||||
| Prepaid expenses and other current assets | 1,025,865 | 712,983 | |||||||
| Total Current Assets | 238,492,039 | 202,575,404 | |||||||
| Other Assets | |||||||||
| Prepaid project costs and other long-term assets | 2,007,231 | 1,140,000 | |||||||
| Trademarks | 127,187 | 119,391 | |||||||
| Total Assets | $ | 240,626,457 | $ | 203,834,795 | |||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | $ | 2,046,144 | $ | 847,451 | |||||
| Total Current Liabilities | 2,046,144 | 847,451 | |||||||
| Stockholders’ Equity | |||||||||
| Preferred stock, no shares issued and outstanding at | — | — | |||||||
| Common stock, 37,404,544 shares and 33,407,495 shares issued and outstanding at | 37,405 | 33,407 | |||||||
| Additional paid-in capital | 434,407,448 | 386,719,120 | |||||||
| Accumulated deficit | (195,864,540) | (183,765,183 | ) | ||||||
| Total Stockholders’ Equity | 238,580,313 | 202,987,344 | |||||||
| Total Liabilities and Stockholders’ Equity | $ | 240,626,457 | $ | 203,834,795 | |||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||
| Revenue | $ | — | $ | — | $ | — | $ | — | |||||||||||||
| Operating Expenses | |||||||||||||||||||||
| General and administrative | 3,710,193 | 2,502,637 | 8,044,713 | 5,982,647 | |||||||||||||||||
| Research and development | 3,907,952 | 1,639,864 | 7,255,579 | 3,305,777 | |||||||||||||||||
| Total Operating Expenses | 7,618,145 | 4,142,501 | 15,300,292 | 9,288,424 | |||||||||||||||||
| Operating Loss | (7,618,145 | ) | (4,142,501 | ) | (15,300,292 | ) | (9,288,424 | ) | |||||||||||||
| Other Income | |||||||||||||||||||||
| Interest income | 1,863,627 | 622,067 | 3,200,935 | 996,978 | |||||||||||||||||
| Total Other Income | 1,863,627 | 622,067 | 3,200,935 | 996,978 | |||||||||||||||||
| Net Loss Before Income Taxes | (5,754,518 | ) | (3,520,434 | ) | (12,099,357 | ) | (8,291,446 | ) | |||||||||||||
| Income taxes | — | — | — | — | |||||||||||||||||
| Net Loss | $ | (5,754,518 | ) | $ | (3,520,434 | ) | $ | (12,099,357 | ) | $ | (8,291,446 | ) | |||||||||
| Net Loss Per Common Share | |||||||||||||||||||||
| Basic and diluted | $ | (0.18 | ) | $ | (0.16 | ) | $ | (0.38 | ) | $ | (0.40 | ) | |||||||||
| Weighted Average Number of Common Shares Outstanding | |||||||||||||||||||||
| Basic and diluted | 31,906,688 | 22,257,221 | 31,974,899 | 20,909,752 | |||||||||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||
| Six Months Ended | |||||||||
| 2026 | 2025 | ||||||||
| Operating Activities | |||||||||
| Net Loss | $ | (12,099,357 | ) | $ | (8,291,446 | ) | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||
| Stock-based compensation | 3,940,038 | 2,106,073 | |||||||
| Changes in operating assets and liabilities: | |||||||||
| Prepaid expenses and other current assets | (462,882 | ) | (226,535 | ) | |||||
| Prepaid project costs and other long-term assets | (867,231 | ) | 37,086 | ||||||
| Accounts payable and accrued liabilities | 1,192,693 | 769,792 | |||||||
| (8,296,739 | ) | (5,605,030 | ) | ||||||
| Investing Activities | |||||||||
| Trademarks | (7,796 | ) | (6,116 | ) | |||||
| (7,796 | ) | (6,116 | ) | ||||||
| Financing Activities | |||||||||
| Proceeds from sale of common stock in public offerings | 45,975,049 | 65,344,153 | |||||||
| Issuance costs related to sale of common stock in public offerings | (1,580,932 | ) | (2,221,231 | ) | |||||
| Net proceeds from the exercise of stock options | 10,807 | 633,375 | |||||||
| Payments for taxes related to net share settlement of equity awards | (496,636 | ) | (234,621 | ) | |||||
| Net Cash Provided by Financing Activities | 43,908,288 | 63,521,676 | |||||||
| Net Increase in Cash and Cash Equivalents | 35,603,753 | 57,910,530 | |||||||
| Cash and Cash Equivalents, Beginning of Period | 201,862,421 | 39,990,827 | |||||||
| Cash and Cash Equivalents, End of Period | $ | 237,466,174 | $ | 97,901,357 | |||||
Source: 